Northwell Health

Northwell Health, established in 1997, is a non-profit healthcare organization headquartered in New Hyde Park, New York. It operates 23 hospitals and over 750 outpatient facilities, employing around 68,000 people and serving communities through a network of 13,600 affiliated physicians. Northwell Ventures, its venture capital arm founded in 2013, invests in growth-stage healthcare companies and technologies that enhance Northwell Health's services and patient care. The firm focuses on clinical and non-clinical areas, leading joint ventures and partnerships to drive innovation and ancillary revenue streams for the health system.

Michael Birnbaum

Program Director, Early Treatment Program

Gerard Brogan MD

Senior Vice President and Chief Revenue Officer

Michael Dowling

President and CEO

Saqib Hussain

Director, Information Technology Security (M&A)

Joseph Moscola

Executive Vice President, Enterprise Services

Richard Mulry

CEO and President

Barbara Osborn

Vice President of Public Relations

Thomas Thornton

Senior Vice President

Mark Solazzo

Executive Vice President and COO

Kate O’Donnell

Managing Director

37 past transactions

Ascertain

Series A in 2025
Ascertain is a collaborative venture between Northwell Health and Aegis Ventures, aimed at transforming healthcare through innovative company creation. This organization focuses on systematically developing, launching, and commercializing healthcare AI companies, utilizing a comprehensive platform that integrates medical, technological, data, and business resources. By addressing critical issues related to quality, equity, and cost in healthcare, Ascertain seeks to improve patient care and experience. The organization is dedicated to placing patient needs at the forefront of its business models and technology solutions, ultimately striving to enhance long-term health outcomes and advance the overall quality of care.

Avandra Imaging

Venture Round in 2025
Avandra Imaging is a health technology company that facilitates the sharing and analysis of medical imaging and clinical data. It aims to accelerate medical research and improve patient care by providing a comprehensive data ecosystem for pharmaceutical companies, medical device manufacturers, and researchers.

Truveta

Series C in 2025
Truveta is a health data platform that collaborates with physicians, life science researchers, and others in the healthcare community to compile medical records from partner organizations, connecting treatments with outcomes and various health factors. The platform aggregates data across multiple healthcare systems to identify and harmonize medical information, enabling researchers and clinicians to analyze treatment effectiveness and support informed decision making across patient care.

Prolucent

Series A in 2024
Prolucent Health specializes in technology and services aimed at optimizing healthcare workforce management. The company offers a platform that leverages artificial intelligence and advanced analytics to address labor needs through data-driven decision-making. By modernizing recruitment and improving the utilization and cost of healthcare labor, Prolucent enables employers to effectively manage both full-time and contingent workforce components. Additionally, the platform engages healthcare workers, helping them discover suitable job opportunities.

Clarapath

Series B in 2024
Clarapath specializes in automating laboratory processes for pathology. Its flagship product, Section Star, streamlines microtomy using a tape transfer method. The company offers routine histology services, digital pathology solutions, and quantitative image analysis. Serving academic researchers, clinical labs, and physicians, Clarapath aims to enhance lab medicine quality, safety standards, and throughput while reducing costs.

Hume AI

Series B in 2024
Hume AI, established in 2021, specializes in developing AI models that enable technology to understand and respond to human emotions. Headquartered in New York and San Jose, the company offers a range of products, including expression measurement models, text-to-speech models, and speech-language models, all grounded in advanced research from psychology and machine learning. Hume AI's technology analyzes facial expressions, voice inflections, text, and other data sources to gain insights into human feelings and engagement. By prioritizing scientific rigor and ethical AI practices, Hume AI serves diverse industries, enhancing human-technology interactions with empathy and authenticity.

Optain

Seed Round in 2023
Optain is a manufacturer of medical equipment and software focused on enhancing healthcare accessibility for all individuals. The company specializes in developing retinal imaging technology that allows for noninvasive real-time diagnosis of eye and systemic health conditions. By leveraging advanced artificial intelligence and automation, Optain enables the use of the eye as a diagnostic tool to detect and prevent diseases in their early stages. This innovative approach facilitates prompt and accurate identification of various eye conditions, thereby supporting healthcare providers in delivering effective clinical assistance solutions that simplify illness screening anytime and anywhere.

Memora Health

Venture Round in 2023
Memora Health is a San Francisco-based healthcare technology company that develops an intelligent care enablement platform to automate outpatient communication and digital workflows. The platform helps clinicians focus on top-of-license practice by digitizing and triaging patient-reported concerns and data, enabling proactive two-way communication and support for patients along complex care journeys, and it partners with health systems, health plans, and digital health companies to transform care delivery for care teams and patients.

Neuvotion

Seed Round in 2023
Neuvotion is a medical device company focused on developing neurostimulation products aimed at the rehabilitation and physical therapy markets. The company harnesses targeted neurostimulation and artificial intelligence to restore movement and independence for individuals experiencing movement impairments, such as those arising from strokes or injuries. By enabling users to actively guide their own therapy, Neuvotion provides a patient-centered approach to rehabilitation. Additionally, it offers clinicians advanced tools to monitor patient progress both in-person and remotely, enhancing the therapeutic value of their interventions.

Hume AI

Series A in 2023
Hume AI, established in 2021, specializes in developing AI models that enable technology to understand and respond to human emotions. Headquartered in New York and San Jose, the company offers a range of products, including expression measurement models, text-to-speech models, and speech-language models, all grounded in advanced research from psychology and machine learning. Hume AI's technology analyzes facial expressions, voice inflections, text, and other data sources to gain insights into human feelings and engagement. By prioritizing scientific rigor and ethical AI practices, Hume AI serves diverse industries, enhancing human-technology interactions with empathy and authenticity.

Holmusk

Series B in 2023
Holmusk is a health data analytics company focused on real-world evidence in behavioral health and chronic diseases. It combines specialty behavioral health data with its analytics platform to generate evidence-based insights that support treatment decisions and the development of new therapies. The company offers predictive algorithms and a proprietary modeling platform to analyze real-world data, enabling personalized medicine and data-driven decision making for healthcare providers, researchers, and life sciences organizations.

Lazzaro Medical

Corporate Round in 2022
Lazzaro Medical is a company focused on addressing the needs of patients suffering from tracheobronchomalacia (TBM). It develops a medical device aimed at restoring healthy breathing through minimally invasive surgical techniques. This innovative device facilitates the repair of tracheobronchomalacia, effectively addressing respiratory issues related to tracheal and bronchial conditions. By enabling doctors to perform surgeries with reduced risk, Lazzaro Medical significantly shortens patient recovery times from months to days, thereby improving overall patient outcomes.

Playback Health

Seed Round in 2022
Playback Health designs and develops digital platforms for patient engagement in healthcare. Its core product enables practitioners to create and share personalized multimedia content with patients, enhancing communication about diagnoses, treatments, and post-care instructions. The company's secure, AI-driven SaaS platform integrates with existing systems, automating processes and improving patient outcomes. Currently deployed in 30 hospitals across the U.S.

Violet

Seed Round in 2022
Violet is a platform that helps the healthcare industry deliver more inclusive services. It enables identity-centered care for everyone.

Health Note

Series A in 2022
Health Note is an AI-powered health data management platform that collects patient information through voice and digital intake tools, automatically formats it into clinical notes, and integrates with electronic medical records to streamline documentation and pre-visit workflows. The platform is frictionless and platform-agnostic, enabling patients to participate in their care without apps or portals and reducing administrative burden for clinicians while improving care team efficiency. Founded in 2018 and based in San Francisco, Health Note aims to simplify clinical documentation and EMR integration.

Brightline

Series C in 2022
Brightline, Inc. is a pediatric behavioral health care provider that focuses on supporting children and their families through innovative technology and integrated care. Established in 2019 and headquartered in Palo Alto, California, Brightline offers a range of services including behavioral therapy, psychiatry, medication support, speech-language therapy, and occupational therapy. The company emphasizes virtual behavioral health services and a collaborative care team to address the diverse needs of children at various developmental stages. Originally named Emilio Health, Inc., the company rebranded to Brightline in May 2020, reflecting its commitment to delivering accessible and comprehensive behavioral health solutions.

Ascertain

Seed Round in 2022
Ascertain is a collaborative venture between Northwell Health and Aegis Ventures, aimed at transforming healthcare through innovative company creation. This organization focuses on systematically developing, launching, and commercializing healthcare AI companies, utilizing a comprehensive platform that integrates medical, technological, data, and business resources. By addressing critical issues related to quality, equity, and cost in healthcare, Ascertain seeks to improve patient care and experience. The organization is dedicated to placing patient needs at the forefront of its business models and technology solutions, ultimately striving to enhance long-term health outcomes and advance the overall quality of care.

Transcarent

Series C in 2022
Transcarent is a consumer-directed health and care platform serving employees of self-insured employers and their families. It combines software, technology, health guides, and data science to provide unbiased information, trusted guidance, and access to high-value care. The company connects users with an integrated ecosystem of high-value providers and health services, enabling customers to exercise choice and transparency for addressing a broad range of healthcare challenges.

Nova Leah

Venture Round in 2021
Nova Leah Ltd, founded in 2015 and headquartered in Dundalk, Ireland with an additional office in Boston, Massachusetts, specializes in developing SelectEvidence, a comprehensive cybersecurity risk analysis and management solution tailored for medical device manufacturers and healthcare providers. The company offers continuous software updates, 24/7 technical support, and online platform training to ensure the security assurance of medical devices throughout their lifecycle. Nova Leah's approach emphasizes knowledge development, sharing, and collaboration to enhance cybersecurity compliance in the medical field.

Holmusk

Venture Round in 2021
Holmusk is a health data analytics company focused on real-world evidence in behavioral health and chronic diseases. It combines specialty behavioral health data with its analytics platform to generate evidence-based insights that support treatment decisions and the development of new therapies. The company offers predictive algorithms and a proprietary modeling platform to analyze real-world data, enabling personalized medicine and data-driven decision making for healthcare providers, researchers, and life sciences organizations.

Clarapath

Series B in 2021
Clarapath specializes in automating laboratory processes for pathology. Its flagship product, Section Star, streamlines microtomy using a tape transfer method. The company offers routine histology services, digital pathology solutions, and quantitative image analysis. Serving academic researchers, clinical labs, and physicians, Clarapath aims to enhance lab medicine quality, safety standards, and throughput while reducing costs.

Cognixion

Seed Round in 2021
Founded in 2014, Cognixion develops neurotech platforms that enhance communication for individuals with disabilities. Its flagship product is an assisted reality headset featuring Brain-Computer Interface technology, enabling users to translate brain signals into words and actions, facilitating effortless expression and environmental control.

Truveta

Series A in 2021
Truveta is a health data platform that collaborates with physicians, life science researchers, and others in the healthcare community to compile medical records from partner organizations, connecting treatments with outcomes and various health factors. The platform aggregates data across multiple healthcare systems to identify and harmonize medical information, enabling researchers and clinicians to analyze treatment effectiveness and support informed decision making across patient care.

Conversa Health

Series B in 2021
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.

Conversa Health

Series B in 2020
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.

Peerbridge Health

Venture Round in 2019
Peerbridge Health Inc. is a digital health company specializing in advanced remote monitoring solutions for vital signs. The company develops a wireless electrocardiogram (ECG) monitor, Peerbridge Cor, which provides real-time heart data to physicians and allows for continuous arrhythmia detection over seven days. In addition to Peerbridge Cor, the company offers products like Peerbridge CorHRV and Peerbridge Cor+, which monitor a range of vital signs including heart rate rhythm, respiratory rate, temperature, oxygen saturation, and heart rate variability. Founded in 2012 in New York by Angelo Acquista, Peerbridge Health holds two pioneering patents for medical-grade monitoring of vital signs, with additional patents pending. By enhancing the accuracy and affordability of diagnoses, Peerbridge Health aims to improve patient outcomes and support various medical, wellness, and performance-based monitoring needs.

Gauss Surgical

Series C in 2018
Gauss Surgical, Inc. is a medical technology company that specializes in real-time blood monitoring solutions to enhance patient outcomes in surgical and obstetric settings. Founded in 2011 and headquartered in Los Altos, California, Gauss Surgical develops the Triton system, which includes various models suited for different medical needs. Triton assists healthcare professionals in monitoring and estimating blood loss during procedures, allowing for timely intervention in cases of hemorrhage. The system offers objective metrics for blood loss, thereby facilitating better clinical decision-making regarding transfusions. Serving the healthcare sector primarily in the United States, Gauss Surgical's products are designed to integrate seamlessly into existing medical practices, using sophisticated algorithms and HIPAA-compliant technology to deliver accurate monitoring in real time.

Arterys

Series B in 2017
Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

Vestagen

Venture Round in 2017
Vestagen Technical Textiles is a company based in Orlando, Florida, that specializes in the development, manufacturing, and marketing of advanced textile products and technologies. Founded in 2009, Vestagen holds exclusive North American rights to patented Swiss technologies for medical textiles, which can be adapted for various applications, including medical uniforms and athletic apparel. The company focuses on addressing the critical need for continuous-wear solutions in the healthcare industry. Its flagship product, VESTEX Active Barrier, is designed to protect healthcare workers and patients by significantly reducing the risks associated with fluid exposure during routine use of general-purpose attire. This innovative fabric helps to minimize the acquisition and retention of harmful microorganisms on clothing, enhancing safety in healthcare settings.

Salaso Health Solutions

Venture Round in 2017
Salaso is a developer of a software as a service platform that enables physiotherapists and other healthcare professionals to prescribe and deliver high-quality exercise videos to patients via smartphones, tablets, or personal computers. The platform includes an e-learning tool designed to engage patients with the content and promote adherence to prescribed home exercise programs. By facilitating the delivery of physiotherapy exercises, Salaso aims to support the recovery process for patients recovering from injuries, ensuring that healthcare providers can effectively manage and monitor their patients' rehabilitation efforts.

Conversa Health

Series A in 2017
Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.

Peerbridge Health

Venture Round in 2017
Peerbridge Health Inc. is a digital health company specializing in advanced remote monitoring solutions for vital signs. The company develops a wireless electrocardiogram (ECG) monitor, Peerbridge Cor, which provides real-time heart data to physicians and allows for continuous arrhythmia detection over seven days. In addition to Peerbridge Cor, the company offers products like Peerbridge CorHRV and Peerbridge Cor+, which monitor a range of vital signs including heart rate rhythm, respiratory rate, temperature, oxygen saturation, and heart rate variability. Founded in 2012 in New York by Angelo Acquista, Peerbridge Health holds two pioneering patents for medical-grade monitoring of vital signs, with additional patents pending. By enhancing the accuracy and affordability of diagnoses, Peerbridge Health aims to improve patient outcomes and support various medical, wellness, and performance-based monitoring needs.

HealthReveal

Series A in 2017
HealthReveal is a company that offers a cloud-based platform for clinical analytics. This platform uses advanced analytics and biomonitoring technology to continually monitor and analyze patient physiology and care by integrating real-time data streams from various sources like clinical, operational, and biometric data. The primary goal of HealthReveal's platform is to ensure adherence to evidence-based care guidelines, enabling early detection and treatment of chronic diseases, which can help patients recover faster and reduce healthcare costs.

Clarapath

Venture Round in 2017
Clarapath specializes in automating laboratory processes for pathology. Its flagship product, Section Star, streamlines microtomy using a tape transfer method. The company offers routine histology services, digital pathology solutions, and quantitative image analysis. Serving academic researchers, clinical labs, and physicians, Clarapath aims to enhance lab medicine quality, safety standards, and throughput while reducing costs.

PurpleSun

Venture Round in 2016
PurpleSun is an early stage healthcare technology company based out of New York City. They are focused on providing smart, light-based technology solutions to the healthcare industry for infection prevention, diagnostics and treatment. Their company’s novel light technology platform will be utilized throughout the continuum of care, within hospitals, long term care and surgical centers. The smart devices will set the stage for patient safety through the highest of quality in medical equipment disinfection. Their goal is to prevent healthcare acquired infections, which will ultimately save lives, reduce costs and enhance safety for patients and caregivers. Their clinical data proves best in class efficacy and performance of our platform, and positions PurpleSun to illuminate the healthcare arena.

Avizia

Series A in 2016
Avizia is a provider of telehealth and remote conferencing solutions designed to facilitate comprehensive telehealth programs within healthcare systems. The company focuses on enhancing collaborative care by connecting medical professionals across distances through its innovative telemedicine platform. Avizia’s end-to-end solution encompasses telemedicine devices, workflow management software, and integration with electronic health records, alongside a variety of peripherals such as digital stethoscopes and examination cameras. This platform allows healthcare providers to conduct remote medical consultations and training sessions, simulating an in-person experience. By leveraging advanced video technology, Avizia enables real-time, high-definition video collaboration among patients and healthcare professionals, thereby streamlining care coordination and expanding access to medical expertise.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.